
51 - 200 employees
Founded 2007
🏥 Healthcare
🔧 Hardware
💰 $42M Series D - Phagenesis on 2024-03
Healthcare • Hardware
Phagenesis is a medical technology company that developed the Phagenyx System, a bedside neurostimulation device delivering pharyngeal electrical stimulation (PES) to restore swallowing function and accelerate recovery from post-stroke dysphagia. Supported by more than 30 publications and recent inclusion of PES in the American Heart Association/American Stroke Association guideline, Phagenyx is CE marked and has received FDA de novo classification for sale in the United States; it is intended for use in adult patients with neurogenic dysphagia and is used in hospitals and critical care settings to enable earlier oral nutrition and reduce aspiration risk, ICU time, and overall length of stay.
🔥 8 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2007
🏥 Healthcare
🔧 Hardware
💰 $42M Series D - Phagenesis on 2024-03
Healthcare • Hardware
Phagenesis is a medical technology company that developed the Phagenyx System, a bedside neurostimulation device delivering pharyngeal electrical stimulation (PES) to restore swallowing function and accelerate recovery from post-stroke dysphagia. Supported by more than 30 publications and recent inclusion of PES in the American Heart Association/American Stroke Association guideline, Phagenyx is CE marked and has received FDA de novo classification for sale in the United States; it is intended for use in adult patients with neurogenic dysphagia and is used in hospitals and critical care settings to enable earlier oral nutrition and reduce aspiration risk, ICU time, and overall length of stay.
• Build the strategy, infrastructure, and institutional relationships from the ground up across four markets: the United States, DACH, United Kingdom, and Ireland. • Lead the development of the US reimbursement roadmap. • Partner with CMRA to synthesise clinical evidence, economic data, and crosswalk analysis in support of CMS submissions and advocacy. • Drive account-level adherence to correct NTAP billing practices. • Monitor IPPS rulemaking cycles and MedPAC activity; develop proactive positioning and response strategies. • Develop and execute market access strategies for the EU, UK (NHS England), and Ireland (HSE). • Identify reimbursement barriers and accelerants at country level; build and maintain a clear market access roadmap for each region. • Build the company’s global health economic value proposition from the ground up.
• 8+ years of market access, health economics, or reimbursement experience in medical devices, pharmaceutical, or biotechnology. • Deep, demonstrable fluency in US CMS billing and coding infrastructure — including DRG payment logic, IPPS rulemaking, NTAP mechanics, and ICD-10/CPT code strategy. • Proven experience building the evidentiary and financial case for coverage expansion or new payment recognition with CMS. • Ability to navigate complex, multi-stakeholder regulatory and payer environments independently. • Strong health economics foundation — able to build and present budget impact models and value dossiers credibly to payer and C-suite audiences. • Experience working closely with field sales teams as a reimbursement resource and commercial partner. • Exceptional written and verbal communication skills; capable of translating complex reimbursement concepts for clinical, administrative, and executive audiences. • Comfort operating in a start-up or commercial-stage environment — building from scratch, managing ambiguity, and prioritising across competing demands.
• At Phagenesis, we are committed to transforming lives by eliminating the burden of neurogenic dysphagia. • We put patients first, operate with courage and trust, and foster a culture that values innovation, accountability, and a challenger mindset. • Willingness to travel up to 40%, including domestic field travel and periodic international travel to EU/UK markets.
Apply Now🔥 1 hour ago
Director or VP of IT/OT leading convergence of IT and OT across global data centers at Rubix. Driving reliability, scalability, and security of infrastructure for high-performance computing environments.
🔥 6 hours ago
Director of Global Partner Enablement empowering partners through enablement strategies at Sophos. Focusing on channel expertise and AI-driven solutions to enhance partner performance.
🇬🇧 United Kingdom – Remote
💰 Post-IPO Equity on 2021-08
⏰ Full Time
🔴 Lead
👔 Director
🇬🇧 UK Skilled Worker Visa Sponsor
🔥 7 hours ago
Director of Corporate Development leading M&A and strategic finance initiatives for Zepz. Shaping long-term strategy and managing key financial relationships in a dynamic remote environment.
🕒 2 days ago
Lead Research & Insights for a pharma consulting firm focused on strategic insights and innovation. Collaborate with executives to drive impactful decisions and shape industry directions.
🕒 2 days ago
Service Development Director responsible for service innovation and commercial growth at SGS, the leading Testing, Inspection and Certification company.
🗣️🇫🇷 French Required